South & Central America Myopia Treatment Market Forecast to 2030 - Regional Analysis - by Type, Treatment, Age Group, and End User

Description

List of Tables

The South & Central America myopia treatment market was valued at US$ 458.52 million in 2022 and is expected to reach US$ 676.01 million by 2030; it is estimated to register a CAGR of 5.0% from 2022 to 2030.

Rising Availability of Advanced Technologies for Treating the Targeted Myopia Fuels South & Central America Myopia Treatment Market

The rising availability of advanced technologies for treating targeted myopia is a significant opportunity for the myopia treatment market. Advances in technologies such as laser-assisted in-situ keratomileusis (LASIK), photorefractive keratectomy (PRK), and implantable collamer lenses (ICL) have made it possible to correct myopia more effectively and with fewer complications. Various ground-breaking data were also presented during the congress; over 30 abstracts backed by Johnson & Johnson Vision have been approved for presentation. Surgeons can apply the innovative SILK (i.e., Smooth Incision Lenticule Keratomileusis) treatment to treat myopic patients who have astigmatism or do not utilize the ELITATM Platform. The ELITATM Platform offers surgeons an exceptionally smooth and uncomplicated lenticular removal procedure with next-day outcomes and recovery owing to its fast laser delivery technology and ultra-precise laser pulse. These advanced technologies have traditionally been expensive and inaccessible to many patients. Still, as they become more widely available, they present an opportunity for the myopia treatment market to expand its reach and provide better treatment options to a larger patient population. In addition to these advanced technologies, other emerging treatments such as orthokeratology (ortho-k) and atropine eye drops are gaining popularity as effective methods for managing myopia. The popular orthokeratology contact lens is the latest CooperVision myopia control product to gain the CE Mark, joining EyeDream and Paragon CRT ortho-k designs, MiSight day soft contact lenses, and SightGlass Vision Diffusion Optics Technology spectacle lenses. These non-invasive treatments can be more affordable than surgical options, making them accessible to a wider range of patients. Overall, the rising availability of advanced technologies for treating targeted myopia presents a significant opportunity for the myopia treatment market. By providing patients with more effective and accessible treatment options, the market can help improve vision health outcomes and address a significant unmet need in the global healthcare landscape.

South & Central America Myopia Treatment Market Overview

South & Central America includes Argentina, Brazil, and the Rest of South & Central America. The myopia treatment market in the region is expected to have several growth opportunities. The rise in the development of the medical industry in Brazil is likely to create significant growth opportunities for market growth. Similarly, Argentina's growing medical device industry is also expected to offer growth opportunities for the myopia treatment market.

The myopia treatment market in Brazil has witnessed significant growth due to the escalating prevalence of myopia across the country. The spread of myopia in Brazil can be attributed to various factors. Urbanization and changing lifestyles have led to increased near-work activities, such as prolonged hours spent on digital devices and reading, contributing to the development and progression of myopia. Additionally, limited outdoor activities and reduced exposure to natural light among children and adults have been linked to a higher incidence of myopia.

South & Central America Myopia Treatment Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Myopia Treatment Market Segmentation

The South & Central America myopia treatment market is categorized into type, treatment, age group, end user, and country.

Based on type, the South & Central America myopia treatment market is segmented into high myopia, degenerative myopia, and progressive myopia. The high myopia segment held the largest South & Central America myopia treatment market share in 2022.

In terms of treatment, the South & Central America myopia treatment market is segmented into low-dose atropine eye drops, contact lenses, ortho-k, and refractive surgery. The low-dose atropine eye drops segment held the largest South & Central America myopia treatment market share in 2022. Furthermore, the refractive surgery segment is subcategorized into LASIK and PRK.

By age group, the South & Central America myopia treatment market is bifurcated into adult myopia and childhood myopia. The adult myopia segment held a larger South & Central America myopia treatment market share in 2022.

Based on end user, the South & Central America myopia treatment market is categorized into hospitals and clinics, specialty clinics, and refractive surgery centers. The hospitals and clinics segment held the largest South & Central America myopia treatment market share in 2022.

Based on country, the South & Central America myopia treatment market is categorized into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America myopia treatment market share in 2022.

Bausch Health Companies Inc, Alcon AG, CooperVision Inc, Johnson & Johnson Vision Care Inc, Nidek Co Ltd, and Carl Zeiss AG are some of the leading companies operating in the South & Central America myopia treatment market.

Product Code: BMIRE00030554

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. South & Central America Myopia Treatment Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Market Share Analysis, By Companies

5. South & Central America Myopia Treatment Market - Key Market Dynamics

5.1 South & Central America Myopia Treatment Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Rising Prevalence of Myopia
- 5.2.2 Increased Awareness of Myopia Treatment
5.3 Market Restraints
- 5.3.1 Lack of Skilled Professionals
5.4 Market Opportunities
- 5.4.1 Rising Availability of Advanced Technologies for Treating The Targeted Myopia
5.5 Future Trends
- 5.5.1 Application of Artificial Intelligence in Myopia Treatment
5.6 Impact of Drivers and Restraints:

6. Myopia Treatment Market - South & Central America Market Analysis

7. South & Central America Myopia Treatment Market Analysis - by Type

7.1 High Myopia
- 7.1.1 Overview
- 7.1.2 High Myopia: South & Central America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Degenerative Myopia
- 7.2.1 Overview
- 7.2.2 Degenerative Myopia: South & Central America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Progressive Myopia
- 7.3.1 Overview
- 7.3.2 Progressive Myopia: South & Central America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Myopia Treatment Market Analysis - by Treatment

8.1 Low-Dose Atropine Eye Drops
- 8.1.1 Overview
- 8.1.2 Low-Dose Atropine Eye Drops: South & Central America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Refractive Surgery
- 8.2.1 Overview
- 8.2.2 Refractive Surgery: South & Central America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
- 8.2.3 LASIK
- 8.2.4 PRK
8.3 Contact Lenses
- 8.3.1 Overview
- 8.3.2 Contact Lenses: South & Central America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Ortho-K
- 8.4.1 Overview
- 8.4.2 Ortho-K: South & Central America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Myopia Treatment Market Analysis - by Age Group

9.1 Adult Myopia
- 9.1.1 Overview
- 9.1.2 Adult Myopia: South & Central America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9.2 Childhood Myopia
- 9.2.1 Overview
- 9.2.2 Childhood Myopia: South & Central America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Myopia Treatment Market Analysis - by End User

10.1 Hospitals and Clinics
- 10.1.1 Overview
- 10.1.2 Hospitals and Clinics: South & Central America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
10.2 Specialty Clinics
- 10.2.1 Overview
- 10.2.2 Specialty Clinics: South & Central America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
10.3 Refractive Surgery Centers
- 10.3.1 Overview
- 10.3.2 Refractive Surgery Centers: South & Central America Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)

11. South & Central America Myopia Treatment Market - Country Analysis

11.1 Overview
11.2 South & Central America
- 11.2.1 South & Central America: Myopia Treatment Market - Revenue and Forecast Analysis - by Country
  - 11.2.1.1 South & Central America: Myopia Treatment Market - Revenue and Forecast Analysis - by Country
  - 11.2.1.2 Brazil
  - 11.2.1.3 Brazil: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.1.3.1 Brazil: Myopia Treatment Market Breakdown, by Type
    - 11.2.1.3.2 Brazil: Myopia Treatment Market Breakdown, by Treatment
    - 11.2.1.3.3 Brazil: Myopia Treatment Market Breakdown, by Refractive Surgery
    - 11.2.1.3.4 Brazil: Myopia Treatment Market Breakdown, by Age Group
    - 11.2.1.3.5 Brazil: Myopia Treatment Market Breakdown, by End User
  - 11.2.1.4 Argentina
  - 11.2.1.5 Argentina: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.1.5.1 Argentina: Myopia Treatment Market Breakdown, by Type
    - 11.2.1.5.2 Argentina: Myopia Treatment Market Breakdown, by Treatment
    - 11.2.1.5.3 Argentina: Myopia Treatment Market Breakdown, by Refractive Surgery
    - 11.2.1.5.4 Argentina: Myopia Treatment Market Breakdown, by Age Group
    - 11.2.1.5.5 Argentina: Myopia Treatment Market Breakdown, by End User
  - 11.2.1.6 Rest of South & Central America
  - 11.2.1.7 Rest of South & Central America: Myopia Treatment Market - Revenue and Forecast to 2030 (US$ Million)
    - 11.2.1.7.1 Rest of South & Central America: Myopia Treatment Market Breakdown, by Type
    - 11.2.1.7.2 Rest of South & Central America: Myopia Treatment Market Breakdown, by Treatment
    - 11.2.1.7.3 Rest of South & Central America: Myopia Treatment Market Breakdown, by Refractive Surgery
    - 11.2.1.7.4 Rest of South & Central America: Myopia Treatment Market Breakdown, by Age Group
    - 11.2.1.7.5 Rest of South & Central America: Myopia Treatment Market Breakdown, by End User

12. Industry Landscape

12.1 Overview
12.2 Growth Strategies in Myopia Treatment Market
12.3 Organic Growth Strategies
- 12.3.1 Overview
12.4 Inorganic Growth Strategies
- 12.4.1 Overview

13. Company Profiles

13.1 Bausch Health Companies Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Alcon AG
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 CooperVision Inc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Johnson & Johnson Vision Care Inc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Nidek Co Ltd
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Carl Zeiss AG
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments

14. Appendix

14.1 About The Insight Partners
14.2 Glossary of Terms